30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Navidea Biopharmaceuticals Inc (NAVB)

Track

Stock chart
Ticker: NAVB Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Scott John K Jr.
1 purchase — total 0 USD
Buy 10 Apr 2022
Value US$1,833,201.76 | Price 75.70 | Shares 41,442
Buy 17 Sep 2021
Value US$4,659,290.56 | Price 19.28 | Shares 32,413
Buy 23 Apr 2021
Value US$16,000.00 | Price 1.60 | Shares 10,000
Buy 29 Mar 2021
Value US$44,505.00 | Price 2.07 | Shares 21,500
Buy 3 Mar 2021
Value US$34,650.00 | Price 2.31 | Shares 15,000
Buy 28 Dec 2020
Value US$10,350.00 | Price 2.07 | Shares 5,000
Buy 30 Aug 2020
Value US$25,000.00 | Price 5.00 | Shares 5,000
Buy 20 Feb 2020
Value US$5,400.00 | Price 1.08 | Shares 5,000
Buy 13 Feb 2020
Value US$2,017,499.65 | Price 0.85 | Shares 2,373,529
Buy 6 Dec 2019
Value US$499,999.50 | Price 0.90 | Shares 555,555
Buy 18 Jun 2019
Value US$3,000,000.00 | Price 0.75 | Shares 4,000,000
Buy 5 Jun 2019
Value US$1,258.30 | Price 1.26 | Shares 1,000
Buy 17 May 2019
Value US$4,904.40 | Price 1.46 | Shares 3,350
Buy 17 May 2019
Value US$1,462.90 | Price 1.46 | Shares 1,000
Buy 16 May 2019
Value US$2,180.40 | Price 1.45 | Shares 1,500
Buy 15 May 2019
Value US$1,447.70 | Price 1.45 | Shares 1,000
Buy 14 May 2019
Value US$3,679.20 | Price 1.84 | Shares 2,000
Buy 13 May 2019
Value US$4,855.20 | Price 1.90 | Shares 2,550
Buy 13 May 2019
Value US$4,594.56 | Price 1.91 | Shares 2,400
Buy 22 Mar 2019
Value US$50,000.02 | Price 0.14 | Shares 357,143
Buy 29 Jun 2017
Value US$10,586.00 | Price 0.53 | Shares 20,000
Buy 30 May 2017
Value US$3,316.64 | Price 0.44 | Shares 7,600
Buy 22 May 2017
Value US$5,038.88 | Price 0.45 | Shares 11,200
Buy 19 May 2017
Value US$6,387.12 | Price 0.45 | Shares 14,159
Buy 29 May 2015
Value US$13,098.00 | Price 1.31 | Shares 10,000
Buy 14 Nov 2014
Value US$31,889.70 | Price 1.12 | Shares 28,359
Buy 13 Nov 2014
Value US$75,853.49 | Price 1.06 | Shares 71,641
Buy 10 Nov 2014
Value US$10,300.00 | Price 1.03 | Shares 10,000
Sale 2 Sep 2014
Value US$81,552.00 | Price 1.36 | Shares 60,000
Buy 12 May 2014
Value US$142.90 | Price 1.43 | Shares 100
Buy 12 May 2014
Value US$712.50 | Price 1.43 | Shares 500
Buy 12 May 2014
Value US$6,283.20 | Price 1.43 | Shares 4,400
Buy 9 May 2014
Value US$13,400.00 | Price 1.34 | Shares 10,000
Buy 8 Nov 2013
Value US$14,715.00 | Price 1.35 | Shares 10,900
Buy 8 Nov 2013
Value US$5,005.00 | Price 1.43 | Shares 3,500
Buy 8 Nov 2013
Value US$6,950.00 | Price 1.39 | Shares 5,000
Buy 8 Nov 2013
Value US$29,000.00 | Price 1.45 | Shares 20,000
Buy 8 Nov 2013
Value US$27,158.00 | Price 1.36 | Shares 20,000
Buy 15 Mar 2013
Value US$49,350.00 | Price 2.82 | Shares 17,500
Buy 15 Mar 2013
Value US$4,995.00 | Price 2.70 | Shares 1,850
Buy 15 Mar 2013
Value US$18,893.00 | Price 2.70 | Shares 7,000
Buy 15 Mar 2013
Value US$13,550.00 | Price 2.71 | Shares 5,000
Buy 15 Mar 2013
Value US$13,550.00 | Price 2.71 | Shares 5,000
Buy 10 Oct 2012
Value US$94,796.80 | Price 2.56 | Shares 37,030
Sale 21 Sep 2012
Value US$15,911.64 | Price 3.24 | Shares 4,911
Sale 19 Sep 2012
Value US$69,874.00 | Price 3.22 | Shares 21,700
Buy 14 Sep 2012
Value US$40,500.00 | Price 2.70 | Shares 15,000
Buy 12 Sep 2012
Value US$13,185.00 | Price 2.64 | Shares 5,000
Buy 12 Sep 2012
Value US$13,200.00 | Price 2.64 | Shares 5,000
Buy 11 Sep 2012
Value US$10,552.00 | Price 2.64 | Shares 4,000
Sale 10 Sep 2012
Value US$996,001.11 | Price 3.69 | Shares 269,919
Sale 10 Sep 2012
Value US$76,875.00 | Price 3.75 | Shares 20,500
Sale 7 Sep 2012
Value US$428,618.91 | Price 3.61 | Shares 118,731
Sale 6 Sep 2012
Value US$8,162.00 | Price 3.71 | Shares 2,200
Sale 5 Sep 2012
Value US$245,322.00 | Price 3.78 | Shares 64,900
Sale 4 Sep 2012
Value US$780,979.80 | Price 3.80 | Shares 205,521
Buy 15 Aug 2012
Value US$17,895.00 | Price 3.58 | Shares 5,000
Planned sale 19 Dec 2011
Value US$19,847.56 | Price 2.54 | Shares 7,814
Planned sale 16 Dec 2011
Value US$103,355.70 | Price 2.45 | Shares 42,186
Planned sale 21 Nov 2011
Value US$21,900.00 | Price 2.19 | Shares 10,000
Planned sale 18 Nov 2011
Value US$13,725.00 | Price 2.25 | Shares 6,100
Planned sale 1 Nov 2011
Value US$79,253.40 | Price 2.76 | Shares 28,715
Planned sale 1 Nov 2011
Value US$34,375.00 | Price 2.75 | Shares 12,500
Planned sale 17 Oct 2011
Value US$144,500.00 | Price 2.89 | Shares 50,000
Buy 15 Sep 2011
Value US$30,780.00 | Price 3.08 | Shares 10,000
Buy 22 Aug 2011
Value US$2,816.00 | Price 2.56 | Shares 1,100
Buy 22 Aug 2011
Value US$256.00 | Price 2.56 | Shares 100
Buy 22 Aug 2011
Value US$1,300.00 | Price 2.60 | Shares 500
Buy 22 Aug 2011
Value US$7,047.00 | Price 2.61 | Shares 2,700
Buy 22 Aug 2011
Value US$26,100.00 | Price 2.61 | Shares 10,000
Buy 19 Aug 2011
Value US$50,200.00 | Price 2.51 | Shares 20,000
Buy 19 Aug 2011
Value US$38,250.00 | Price 2.55 | Shares 15,000
Planned sale 3 Jun 2011
Value US$1,057,680.00 | Price 4.52 | Shares 234,000
Planned sale 2 Jun 2011
Value US$1,104,420.00 | Price 4.74 | Shares 233,000
Sale 27 May 2011
Value US$261,000.00 | Price 5.22 | Shares 50,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-03 2022-04-10 B Purchase
1.4
Scott John K Jr.
Non-Executive Director Large shareholder
41,442
75.70
US$1,833,202 		41,442 75.70 US$1,833,202
2021-09-17 2021-09-17 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
32,413 -23.9%
19.28
US$4,659,291 		32,413 -23.9% 19.28 US$4,659,291
2021-04-26 2021-04-23 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
12,905 -24.9%
422.73
US$1,923,881 		12,905 -24.9% 422.73 US$1,923,881
2021-03-29 2021-03-29 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
21,500 +84.3%
2.07
US$44,505 		21,500 +84.3% 2.07 US$44,505
2021-03-03 2021-03-03 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
15,000 +142.9%
2.31
US$34,650 		15,000 +142.9% 2.31 US$34,650
2020-12-30 2020-12-28 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
5,000 +90.9%
2.07
US$10,350 		5,000 +90.9% 2.07 US$10,350
2020-09-02 2020-08-30 B Purchase
1.4
Scott John K Jr.
Large shareholder
5,000 +0.1%
5.00
US$25,000 		5,000 +0.1% 5.00 US$25,000
2020-02-20 2020-02-20 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
5,000 +38.6%
1.08
US$5,400 		5,000 +38.6% 1.08 US$5,400
2020-02-19 2020-02-13 B Purchase
1.4
Scott John K Jr.
Large shareholder
2,373,529 +41.9%
0.85
US$2,017,500 		2,373,529 +41.9% 0.85 US$2,017,500
2019-12-11 2019-12-06 B Purchase Scott John K Jr. Large shareholder
555,555 +10.9%
0.90
US$500,000 		555,555 +10.9% 0.90 US$500,000
2019-06-21 2019-06-18 B Purchase
1.4
Scott John K Jr.
Large shareholder
4,000,000 +359.4%
0.75
US$3,000,000 		4,000,000 +359.4% 0.75 US$3,000,000
2019-06-07 2019-06-05 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,000 +8.4%
1.26
US$1,258 		1,000 +8.4% 1.26 US$1,258
2019-05-21 2019-05-17 B Purchase
3.2
Rouan Sarah Kathryn
3,350 +67.0%
1.46
US$4,904 		3,350 +67.0% 1.46 US$4,904
2019-05-17 2019-05-17 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,000 +9.1%
1.46
US$1,463 		1,000 +9.1% 1.46 US$1,463
2019-05-17 2019-05-16 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,500 +15.9%
1.45
US$2,180 		1,500 +15.9% 1.45 US$2,180
2019-05-15 2019-05-15 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,000 +11.8%
1.45
US$1,448 		1,000 +11.8% 1.45 US$1,448
2019-05-15 2019-05-14 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
2,000 +31.0%
1.84
US$3,679 		2,000 +31.0% 1.84 US$3,679
2019-05-15 2019-05-13 B Purchase
1.4
Bruck Claudine
2,550 +51.0%
1.90
US$4,855 		2,550 +51.0% 1.90 US$4,855
2019-05-15 2019-05-13 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
2,400 +59.3%
1.91
US$4,595 		2,400 +59.3% 1.91 US$4,595
2019-03-25 2019-03-22 B Purchase
1.4
Scott John K Jr.
Large shareholder
357,143 +1.6%
0.14
US$50,000 		357,143 +1.6% 0.14 US$50,000
2017-07-03 2017-06-29 B Purchase Regan William J.

SVP & CCO

Officer
20,000 +13.1%
0.53
US$10,586 		20,000 +13.1% 0.53 US$10,586
2017-05-31 2017-05-30 B Purchase Latkin Jed

COO and CFO
7,600 +17.9%
0.44
US$3,317 		7,600 +17.9% 0.44 US$3,317
2017-05-23 2017-05-22 B Purchase Latkin Jed

COO and CFO
11,200 +35.7%
0.45
US$5,039 		11,200 +35.7% 0.45 US$5,039
2017-05-23 2017-05-19 B Purchase Latkin Jed

COO and CFO
14,159 +82.3%
0.45
US$6,387 		14,159 +82.3% 0.45 US$6,387
2015-06-01 2015-05-29 B Purchase Troup Gordon A Non-Executive Director
10,000 +4.7%
1.31
US$13,098 		10,000 +4.7% 1.31 US$13,098
2014-11-17 2014-11-14 B Purchase GOLDBERG MICHAEL M Non-Executive Director
28,359 +10.9%
1.12
US$31,890 		28,359 +10.9% 1.12 US$31,890
2014-11-17 2014-11-13 B Purchase GOLDBERG MICHAEL M Non-Executive Director
71,641 +37.8%
1.06
US$75,853 		71,641 +37.8% 1.06 US$75,853
2014-11-12 2014-11-10 B Purchase FORD BRENDAN A Non-Executive Director
10,000 +5.9%
1.03
US$10,300 		10,000 +5.9% 1.03 US$10,300
2014-09-04 2014-09-02 S Sale Nordlicht Mark Large shareholder
60,000 -0.4%
1.36
US$81,552 		60,000 -0.4% 1.36 US$81,552
2014-05-15 2014-05-12 B Purchase Regan William J.

SVP-Global Reg Affairs&Quality

Officer
100 +1.0%
1.43
US$143 		100 +1.0% 1.43 US$143
2014-05-15 2014-05-12 B Purchase Regan William J.

SVP-Global Reg Affairs&Quality

Officer
500 +5.3%
1.43
US$712 		500 +5.3% 1.43 US$712
2014-05-15 2014-05-12 B Purchase Regan William J.

SVP-Global Reg Affairs&Quality

Officer
4,400 +88.0%
1.43
US$6,283 		4,400 +88.0% 1.43 US$6,283
2014-05-13 2014-05-09 B Purchase PYKETT MARK JEROME

CEO

Executive Director
10,000 +3.5%
1.34
US$13,400 		10,000 +3.5% 1.34 US$13,400
2013-11-08 2013-11-08 B Purchase PYKETT MARK JEROME

CEO

Executive Director
10,900 +2.8%
1.35
US$14,715 		10,900 +2.8% 1.35 US$14,715
2013-11-08 2013-11-08 B Purchase Cope Frederick O

SVP

Officer
3,500 +4.0%
1.43
US$5,005 		3,500 +4.0% 1.43 US$5,005
2013-11-08 2013-11-08 B Purchase LARSON BRENT L

EVP, CFO, Treas & Secy

Officer
5,000 +1.8%
1.39
US$6,950 		5,000 +1.8% 1.39 US$6,950
2013-11-08 2013-11-08 B Purchase FORD BRENDAN A Non-Executive Director
20,000 +16.8%
1.45
US$29,000 		20,000 +16.8% 1.45 US$29,000
2013-11-08 2013-11-08 B Purchase Troup Gordon A Non-Executive Director
20,000 +15.8%
1.36
US$27,158 		20,000 +15.8% 1.36 US$27,158
2013-03-18 2013-03-15 B Purchase Tulip Thomas H.

EVP & Chief Business Officer

Officer
17,500 +63.6%
2.82
US$49,350 		17,500 +63.6% 2.82 US$49,350
2013-03-18 2013-03-15 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
1,850 +0.5%
2.70
US$4,995 		1,850 +0.5% 2.70 US$4,995
2013-03-18 2013-03-15 B Purchase Troup Gordon A Non-Executive Director
7,000 +5.9%
2.70
US$18,893 		7,000 +5.9% 2.70 US$18,893
2013-03-18 2013-03-15 B Purchase Regan William J.

SVP-Global Regulatory Strategy

Officer
5,000 +inf%
2.71
US$13,550 		5,000 +inf% 2.71 US$13,550
2013-03-18 2013-03-15 B Purchase FORD BRENDAN A Non-Executive Director
5,000 +4.4%
2.71
US$13,550 		5,000 +4.4% 2.71 US$13,550
2012-11-09 2012-10-10 B Purchase Platinum-Montaur Life Sciences, LLC Large shareholder
37,030 +0.5%
2.56
US$94,797 		37,030 +0.5% 2.56 US$94,797
2012-11-09 2012-09-21 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
4,911 -0.1%
3.24
US$15,912 		4,911 -0.1% 3.24 US$15,912
2012-11-09 2012-09-19 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
21,700 -0.3%
3.22
US$69,874 		21,700 -0.3% 3.22 US$69,874
2012-09-14 2012-09-14 B Purchase Tulip Thomas H.

EVP & Chief Business officer
15,000 +120.0%
2.70
US$40,500 		15,000 +120.0% 2.70 US$40,500
2012-09-13 2012-09-12 B Purchase Troup Gordon A Non-Executive Director
5,000 +6.9%
2.64
US$13,185 		5,000 +6.9% 2.64 US$13,185
2012-09-13 2012-09-12 B Purchase FORD BRENDAN A Non-Executive Director
5,000 +7.5%
2.64
US$13,200 		5,000 +7.5% 2.64 US$13,200
2012-09-14 2012-09-11 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
4,000 +1.3%
2.64
US$10,552 		4,000 +1.3% 2.64 US$10,552
2012-11-09 2012-09-10 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
269,919 -3.8%
3.69
US$996,001 		269,919 -3.8% 3.69 US$996,001
2012-11-09 2012-09-10 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
20,500 -0.3%
3.75
US$76,875 		20,500 -0.3% 3.75 US$76,875
2012-11-09 2012-09-07 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
118,731 -1.6%
3.61
US$428,619 		118,731 -1.6% 3.61 US$428,619
2012-11-09 2012-09-06 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
2,200 -0.0%
3.71
US$8,162 		2,200 -0.0% 3.71 US$8,162
2012-11-09 2012-09-05 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
64,900 -0.9%
3.78
US$245,322 		64,900 -0.9% 3.78 US$245,322
2012-11-09 2012-09-04 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
205,521 -2.8%
3.80
US$780,980 		205,521 -2.8% 3.80 US$780,980
2012-09-13 2012-08-15 B Purchase Troup Gordon A Non-Executive Director
5,000 +7.5%
3.58
US$17,895 		5,000 +7.5% 3.58 US$17,895
2011-12-20 2011-12-19 PlS Planned sale BUPP DAVID C Non-Executive Director
7,814 -0.3%
2.54
US$19,848 		7,814 -0.3% 2.54 US$19,848
2011-12-20 2011-12-16 PlS Planned sale BUPP DAVID C Non-Executive Director
42,186 -1.5%
2.45
US$103,356 		42,186 -1.5% 2.45 US$103,356
2011-11-22 2011-11-21 PlS Planned sale BUPP DAVID C Non-Executive Director
10,000 -0.4%
2.19
US$21,900 		10,000 -0.4% 2.19 US$21,900
2011-11-22 2011-11-18 PlS Planned sale BUPP DAVID C Non-Executive Director
6,100 -0.2%
2.25
US$13,725 		6,100 -0.2% 2.25 US$13,725
2011-11-02 2011-11-01 PlS Planned sale BROWN RODGER A

Vice President

Officer
28,715 -13.1%
2.76
US$79,253 		28,715 -13.1% 2.76 US$79,253
2011-11-02 2011-11-01 PlS Planned sale LARSON BRENT L

SVP, CFO, Treas & Secy

Officer
12,500 -4.5%
2.75
US$34,375 		12,500 -4.5% 2.75 US$34,375
2011-10-19 2011-10-17 PlS Planned sale BUPP DAVID C Non-Executive Director
50,000 -1.9%
2.89
US$144,500 		50,000 -1.9% 2.89 US$144,500
2011-10-18 2011-09-15 B Purchase DRAKE PETER F Non-Executive Director
10,000 +inf%
3.08
US$30,780 		10,000 +inf% 3.08 US$30,780
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
1,100 +inf%
2.56
US$2,816 		1,100 +inf% 2.56 US$2,816
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
100 +3.1%
2.56
US$256 		100 +3.1% 2.56 US$256
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
500 +18.5%
2.60
US$1,300 		500 +18.5% 2.60 US$1,300
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
2,700 +inf%
2.61
US$7,047 		2,700 +inf% 2.61 US$7,047
2011-08-23 2011-08-22 B Purchase Troup Gordon A Non-Executive Director
10,000 +25.0%
2.61
US$26,100 		10,000 +25.0% 2.61 US$26,100
2011-08-23 2011-08-19 B Purchase FORD BRENDAN A Non-Executive Director
20,000 +66.7%
2.51
US$50,200 		20,000 +66.7% 2.51 US$50,200
2011-08-23 2011-08-19 B Purchase Rowinsky Eric K Non-Executive Director
15,000 +inf%
2.55
US$38,250 		15,000 +inf% 2.55 US$38,250
2011-06-07 2011-06-03 PlS Planned sale BUPP DAVID C Non-Executive Director
234,000 -8.2%
4.52
US$1,057,680 		234,000 -8.2% 4.52 US$1,057,680
2011-06-03 2011-06-02 PlS Planned sale BUPP DAVID C Non-Executive Director
233,000 -8.4%
4.74
US$1,104,420 		233,000 -8.4% 4.74 US$1,104,420
2011-06-01 2011-05-27 S Sale Blair Anthony K

VP-Manufacturing & Operations

Officer
50,000 -100.0%
5.22
US$261,000 		50,000 -100.0% 5.22 US$261,000
Explore more

More insider trading research around Navidea Biopharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America